drugset / Trial / NCT00885547
Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to: 1. To evaluate the latest effects of TW for IgA nephropathy (IgAN) with asymptomatic abnormal urinalysis. 2. To evaluate the safety and tolerability of TW.
Timeline
- Start
- 2009-03
- Primary completion
- 2011-04
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tripterygium wilfordii | Traditional medicine (herbal / TCM) | 90 mg | — |